The mode of action of anticancer gold-based drugs: a structural perspective (Q27686705)

7

0 references

Alessandro Vergara

6

0 references

Chiara Gabbiani

object named as

Chiara Gabbiani

5

0 references

Luigi Messori

object named as

Luigi Messori

1

0 references

author name string

Federica Scaletti

2

0 references

Lara Massai

3

0 references

Maria A Cinellu

Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure

4

0 references

language of work or name

English

0 references

publication date

3 October 2013

0 references

published in

Chemical Communications

0 references

volume

49

0 references

issue

86

0 references

page(s)

10100-2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

A gold(III) porphyrin complex with antitumor properties targets the Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Cytotoxicity profiles for a series of triorganophosphinegold(I) dithiocarbamates and triorganophosphinegold(I) xanthates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Mechanisms of cytotoxicity of selected organogold(III) compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Solution chemistry and cytotoxic properties of novel organogold(III) compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

A dual cytotoxic and anti-angiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Organogold(III) supramolecular polymers for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

[Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

A categorization of metal anticancer compounds based on their mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Interactions of gold coordination complexes with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Time-dependent, protein-directed growth of gold nanoparticles within a single crystal of lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Interaction of anticancer ruthenium compounds with proteins: high-resolution X-ray structures and raman microscopy studies of the adduct between hen egg white lysozyme and AziRu

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Silver metallation of hen egg white lysozyme: X-ray crystal structure and NMR studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Porous protein crystals as reaction vessels for controlling magnetic properties of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

The crystal structure analysis of the relative binding of cisplatin and carboplatin in a mixture with histidine in a protein studied at 100 and 300 K with repeated X-ray irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Structural studies of the effect that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine in a protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

A dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H

Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC46400H